Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Coronary Artery Disease and the bad dual: Homocysteine and Lipoprotein (a)
Session:
SESSÃO DE COMUNICAÇÕES ORAIS 07 - PRÉMIO FERRER MELHOR COMUNICAÇÃO ORAL EM PREVENÇÃO SECUNDÁRIA
Speaker:
Francisco Sousa
Congress:
CPC 2025
Topic:
J. Preventive Cardiology
Theme:
28. Risk Factors and Prevention
Subtheme:
28.3 Secondary Prevention
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Francisco Sousa; Maria Isabel Mendonça; Débora Sá; Gonçalo Abreu; Matilde Ferreira; Eva Henriques; Sofia Borges; Sónia Freitas; Mariana Rodrigues; António Drumond; Ana Célia Sousa; Roberto Palma Dos Reis
Abstract
<p><strong>Introduction</strong>: High homocysteine (Hcy) and Lipoprotein [Lp(a)] levels are independent risk factors for coronary artery disease (CAD) through several<br /> mechanisms, such as endothelial dysfunction, increased permeability of lipids and inflammation. It promotes the release of free Apo(a) from Lp(a). Free Apo(a) has high fibrin affinity and inhibits plasminogen binding, altering fibrinolysis. Identifying individuals with the dual risk focus on preventive measures might decrease the risk of this atherothrombotic disease.<br /> </p> <p><strong>Aim:</strong> Evaluate Hcy and Lp(a) as independent risk factors for CAD in a Portuguese population, establishing the cut-off value for the appearance CAD in our population. Finally, investigate whether there is a positive interaction between these two markers.<br /> </p> <p><strong>Methods:</strong> We performed a case-control study with 1722 coronary patients and 1435 controls (aged 53.0±7.8 years; 77.6% male) matched by sex and age. Hcy and Lp(a) levels were determined and stratified into deciles. Multivariate logistic regression adjusted for age and gender was performed using Hcy and Lp(a) deciles to investigate the independent risk of CAD. Our disease cut-off is the point along the deciles when the risk begins. Finally, a second regression analysis was performed with Hcy and Lp(a) combination and adjusted for age, sex, smoking, hypertension, diabetes, dyslipidemia, BMI≥30Kg/m 2 , physical inactivity and CAD family history to evaluate their synergistic interaction.<br /> </p> <p><strong>Results</strong>: After a multivariate regression concerning Hcy, the first four deciles (lower values) presented CAD protection. From this point (fifth decile), the CAD risk begins, and as Hcy levels increase, CAD risk also increases. In the 10 th decile, the CAD risk was 80% higher than the reference. In the case of Lp(a), the 6 th decile was the reference, starting the significant risk below these. On the 10 th , CAD risk was 200% higher than the reference. The combination of Hcy and Lp(a) higher values had an increased risk of 2.16 (95% CI: 1.73-2.69; p&lt;0.0001).<br /> </p> <p><strong>Conclusion:</strong> High levels of Lp(a) and Hcy were independent risk factors for CAD in our population. There was an interaction between Lp(a) and Hcy that significantly potentiates the CAD risk. These findings highlight the importance of identifying individuals with this dual risk factor of elevated Hcy and Lp(a) to focus on preventive measures that might decrease the CAD risk in our population. This interaction deserves to be investigated in relation to other ethnicities.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site